2021 Focused Update Guidelines on Management of Clostridioides Difficile Infection in Adults

Written By Adventure Administrator
shutterstock_340931609.jpg

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.

Adventure Administrator

Adventure Studios was established in 2006 as a design and development firm offering an alternative to the typical models of executive software services available, including 100% custom construction, an expensive and time-intensive process, or the “one-size-fits-all” services that either lack necessary features or are encumbered by too many.

http://www.adventurestudio.com
Previous

Medicare, Joint Commission Update Antimicrobial Stewardship Requirements
Next

The Impact of an Antibiotic Stewardship Program on the Consumption of Specific Antimicrobials and Their Cost Burden: A Hospital-wide Intervention